Pfizer’s migraine medicine recommended by NICE
The National Institute for Health and Care Excellence (NICE) has…
The National Institute for Health and Care Excellence (NICE) has published final draft guidance on Pfizer’s Rimegepant, recommending it for the first time as a treatment for acute migraines.